Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate

Document Type : Original Article


Department of Pharmaceutics, Novel Drug Delivery Systems Research Center, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran


Background: Many drugs have poor water solubility and so the oral delivery of such drugs is usually associated with limitation of low bioavailability and lack of dose proportionality. Lipid-based liquid crystal (LC) systems are excellent potential formulations for increasing dissolution and bioavailability of drugs. The aim of the present study was to formulate lipid-based LC containing fenofibrate (FFB) as a hydrophobic drug. Materials and Methods: The studied variables included lipid and stabilizer concentrations and the type of stabilizer. The LC formation was identified by the polarized optical microscopic method. The effects of variables on formulation characteristics such as particle size, drug release, and rheological behavior were evaluated. Results: The results showed that the prepared formulations had the particle size between 42 and 503 nm. The drug release profiles showed that FFB had the continuous release from the formulations and the highest dissolution efficiency was seen in formulation prepared by 1.5% of glyceryl monostearate and 0.5% of Pluronic F127 as the stabilizer. The change of stabilizer type from colloidal silica to Pluronic F127 increased the drug release, significantly. Conclusions: In the most formulations of FFB LCs, the DE% was more than the pure drug, and therefore, it seems that the liquid crystalline formulations can be effective for enhancing drug release. Furthermore, drug release rate depended on the stabilizer type so that the presence of colloidal silica caused slower drug release compared to Pluronic F127.


Di L, Fish PV, Mano T. Bridging solubility between drug discovery and development. Drug Discov Today 2012;17:486-95.  Back to cited text no. 1
Bergström CA, Holm R, Jørgensen SA, Andersson SB, Artursson P, Beato S, et al. Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs. Eur J Pharm Sci 2014;57:173-99.  Back to cited text no. 2
Custodio JM, Wu CY, Benet LZ. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev 2008;60:717-33.  Back to cited text no. 3
Sauron R, Wilkins M, Jessent V, Dubois A, Maillot C, Weil A, et al. Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation. Int J Clin Pharmacol Ther 2006;44:64-70.  Back to cited text no. 4
Sanganwar GP, Gupta RB. Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide. Int J Pharm 2008;360:213-8.  Back to cited text no. 5
Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006;34:D668-72.  Back to cited text no. 6
Ming-Thau S, Ching-Min Y, Sokoloski TD. Characterization and dissolution of fenofibrate solid dispersion systems. Int J Pharm 1994;103:137-46.  Back to cited text no. 7
Löbenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000;50:3-12.  Back to cited text no. 8
Guay DR. Micronized fenofibrate: A new fibric acid hypolipidemic agent. Ann Pharmacother 1999;33:1083-103.  Back to cited text no. 9
Granero GE, Ramachandran C, Amidon GL. Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev Ind Pharm 2005;31:917-22.  Back to cited text no. 10
Badens E, Majerik V, Horváth G, Szokonya L, Bosc N, Teillaud E, et al. Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologies. Int J Pharm 2009;377:25-34.  Back to cited text no. 11
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60.  Back to cited text no. 12
Perrut M, Jung J, Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles. Int J Pharm 2005;288:3-10.  Back to cited text no. 13
Junghanns JU, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008;3:295-309.  Back to cited text no. 14
Williams HD, Trevaskis NL, Yeap YY, Anby MU, Pouton CW, Porter CJ, et al. Lipid-based formulations and drug supersaturation: Harnessing the unique benefits of the lipid digestion/absorption pathway. Pharm Res 2013;30:2976-92.  Back to cited text no. 15
O'Reilly JR, Corrigan OI, O'Driscoll CM. The effect of mixed micellar systems, bile acid/fatty acids, on the solubility and intestinal absorption of clofazimine (B663) in the anaesthetized rat. Int J Pharm 1994;109:147-54.  Back to cited text no. 16
Srinarong P, Faber JH, Visser MR, Hinrichs WL, Frijlink HW. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm 2009;73:154-61.  Back to cited text no. 17
Patel AR, Vavia PR. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Pheno Macrocycl Chem 2006;56:247-51.  Back to cited text no. 18
Wei LL, Peixin, W Chandra N, Say Chye JL. Gastric-floating microcapsules provide controlled and sustained release of multiple cardiovascular drugs, J Mater Chem 2013;1:1090-5.  Back to cited text no. 19
Bhargava P, Bhargava S, Daharwal SJ. Self emulsifying drug delivery system: An approach to improve the solubility of poorly water soluble drug. Adv Res Pharm Biol 2011;1:1-9.  Back to cited text no. 20
Yamada K, Yamashita J, Todo H, Miyamoto K, Hashimoto S, Tokudome Y, et al. Preparation and evaluation of liquid-crystal formulations with skin-permeation-enhancing abilities for entrapped drugs. J Oleo Sci 2011;60:31-40.  Back to cited text no. 21
Clogston J, Rathman J, Tomasko D, Walker H, Caffrey M. Phase behavior of a monoacylglycerol: (myverol 18-99K)/water system. Chem Phys Lipids 2000;107:191-220.  Back to cited text no. 22
Lian R, Lu Y, Qi J, Tan Y, Niu M, Guan P, et al. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: Physical characterization and enhanced oral bioavailability. AAPS PharmSciTech 2011;12:1234-40.  Back to cited text no. 23
Drummond CJ, Fong C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interf Sci 1999;4:449-56.  Back to cited text no. 24
Chung H, Kim J, Um JY, Kwon IC, Jeong SY. Self-assembled “nanocubicle” as a carrier for peroral insulin delivery. Diabetologia 2002;45:448-51.  Back to cited text no. 25
Lopes LB, Lopes JL, Oliveira DC, Thomazini JA, Garcia MT, Fantini MC, et al. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: Characterization and study of in vitro and in vivo delivery. Eur J Pharm Biopharm 2006;63:146-55.  Back to cited text no. 26
Boyd BJ, Whittaker DV, Khoo SM, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm 2006;309:218-26.  Back to cited text no. 27
Norling T, Lading P, Engström S, Larsson K, Krog N, Nissen SS, et al. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J Clin Periodontol 1992;19:687-92.  Back to cited text no. 28
Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 1997;13:6964-71.  Back to cited text no. 29
Briggs J, Caffrey M. The temperature-composition phase diagram and mesophase structure characterization of monopentadecenoin in water. Biophys J 1994;67:1594-602.  Back to cited text no. 30
Barauskas J, Landh T. Phase behaviour of the phytantriol/water system, Langmuir. 2003;19:9562-5.  Back to cited text no. 31
Hato M, Minamikawa H. The effects of oligosaccharide stereochemistry on the physical properties of aqueous synthetic glycolipids. Langmuir 1996;12:1658-65.  Back to cited text no. 32
Charman WN, Rogge MC, Boddy AW, Berger BM. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol 1993;33:381-6.  Back to cited text no. 33
Ermer J. Performance parameters, calculation and tests. In: Ermer J, Miller J, editors. Method validation in Pharmaceutical Analysis. New York: Wiley-VCH, Verlag GMBH; 2005. p. 21-119.  Back to cited text no. 34
Nesseem DI. Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. J Pharm Biomed Anal 2001;26:387-99.  Back to cited text no. 35
Ghosh PK, Majithiya RJ, Umrethia ML, Murthy RS. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS PharmSciTech 2006;7:77.  Back to cited text no. 36
Tilley AJ, Drummond CJ, Boyd BJ. Disposition and association of the steric stabilizer pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions. J Colloid Interface Sci 2013;392:288-96.  Back to cited text no. 37
Chong JY, Mulet X, Waddington LJ, Boyd BJ, Drummond CJ. Steric stabilisation of self-assembled cubic lyotropic liquid crystalline nanoparticles: High throughput evaluation of triblock polyethene oxide-polypropylene oxide-polyethene oxide copolymers, Soft Matter 2011;7:4768.  Back to cited text no. 38
Dong YD, Larson I, Hanley T, Boyd BJ. Bulk and dispersed aqueous phase behavior of phytantriol: Effect of Vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir 2006;22:9512-8.  Back to cited text no. 39
Alam MM, Sugiyama Y, Watanabe K, Aramaki K. Phase behavior and rheology of oil-swollen micellar cubic phase and gel emulsions in nonionic surfactant systems. J Colloid Interface Sci 2010;341:267-72.  Back to cited text no. 40
Milak S, Zimmer A. Glycerol monooleate liquid crystalline phases used in drug delivery systems. Int J Pharm 2015;478:569-87.  Back to cited text no. 41
Wei S, Ren J, Li N, Huo W, Gao C. Preparation and pharmacokinetic study of fenofibrate cubic liquid crystalline. Asian J Pharm Sci 2017;17:30193-9.  Back to cited text no. 42